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Urease activityAbstract Three biologically active new Schiff bases, 2-[(3-hydroxybenzylidene)amino]phenol 5, 2-
[(4-hydroxybenzylidene)amino]phenol 6 and 4-[(2-hydroxyphenylimino)methyl]benzene-1,3-diol 7,
were synthesized by the reaction of 2-aminophenol 1 with three different hydroxyl-benzaldehydes
2–4. They were characterized by spectroscopic analysis (IR, 1H NMR, EI-MS) along with elemental
analyses. The products were biological screened out for antioxidant, lipoxygenase inhibition, anti-
bacterial and urease inhibition activities. The compounds 5 and 6 showed potent while 7 showed
moderate antioxidant activity. Compound 6 showed potent whereas 5 and 7 showed signiﬁcant
lipoxygenase inhibition activity. All the target compounds showed excellent activities against Staph-
ylococcus intermedius, Bacillus subtilis, Staphylococcus aureus, Escherichia coli and Salmonella typhi
bacteria. All the compounds showed non-signiﬁcant activity against urease enzyme.
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Schiff bases are azomethine compounds, after the name of
Hugo Schiff (Da Silva et al., 2011), and are prepared by the
condensation of primary amines with aldehydes or ketones
in acid or base catalyst (Dueke-Eze et al., 2011). In organic,
Schiff bases are important intermediates in the synthesis (Rana
et al., 2012). Due to their azomethine moiety, they possess a
remarkable anticancer (Shkawat et al., 1973), antibacterial
46 M. Aslam et al.(More et al., 2001), antifungal (Chaitanya et al., 2010), anti-tu-
mor (Hodnett and Dunn, 1970), herbicides (Samadhiya and
Halve, 2001), anti-inﬂammatory (Sathe et al., 2011) and anal-
gesic (Chinnasamy et al., 2010) activities. They are also used as
pigments, dyes, catalysts, and as polymer stabilizers (Taggi
et al., 2002). Due to the attractive biological activities of Schiff
bases, we have reported the synthesis and biological activities
of various Schiff bases (Aslam et al., 2012).
We herein report the syntheses and characterizations of
three Schiff bases, named 2-[(3-hydroxybenzylidene)amino]-
phenol 5, 2-[(4-hydroxybenzylidene)amino]phenol 6 and 4-
[(2-hydroxyphenylimino)methyl]benzene-1,3-diol 7, derived
from 2-aminophenol 1 and hydroxyl-benzaldehydes 2–4, along
with their antioxidant, lipoxygenase inhibition, antibacterial
and urease inhibition activities.
2. Experimental
2.1. Material and methods
All the solvents and chemicals were purchased from Merck.
The melting points were determined by Gallenkamp apparatus
and are uncorrected. Elemental analyses were carried out by
Perkin–Elmer 2400 Series II elemental analyzer. IR spectra
were measured on Thermo Nicolet Avatar 320 FT-IR spec-
trometer by using KBr pellets. Mass spectra on electron impact
mode were measured on Finnigan MAT-112 spectrometer and
ions are given in m/z. TLC was performed on pre-coated silica
gel G-25-UV254 plates to check the purity. The
1H NMR spec-
tra were performed on Bruker AMX-400 spectrometer in
DMSO-d6 solvent and TMS used as internal standard. Chem-
ical shifts (d) are given in ppm and coupling constants (J) are
reported in Hertz.
2.2. General procedure for the synthesis of Schiff bases 5–7
The reaction mixture of 2-aminophenol 1 (0.01 mol in 50 mL
EtOH) and hydroxybenzaldehydes 2–4 (0.01 mol in 50 mL
EtOH) followed by 3–4 drops of conc. H2SO4, was reﬂuxed
for 3 h at 70 C with constant stirring. The mixture was con-
centrated to one-third of its volume by using rotary evapora-
tor. The conc. mixture was placed at ambient temperature to
obtain the solid products. The products were ﬁltered, washed
with cold methanol and recrystallized with absolute methanol.
The ﬁnal products were dried on anhydrous calcium hydroxide
at reduced pressure. The completion of reaction was moni-
tored by TLC from time to time (Scheme 1).Scheme 1 Synthetic scheme of the Schiff bases 5–7.2.3. 2-[(3-Hydroxybenzylidene)amino]phenol 5
Chocolate solid; yield 75.02%; m.p. 119 C; Anal. Calcd. for
C13H11NO2: C, 73.23, H, 5.20, N, 6.57; found C, 73.41, H,
5.31, N, 6.51; IR (KBr) mmax cm
1: 1680 (C‚N); 1H NMR
(DMSO-6d, 400 MHz, ppm) d: 8.56 (1H, s, AN‚CH, azome-
thine); EI-MS: m/z [M]+ 213.3.
2.4. 2-[(4-Hydroxybenzylidene)amino]phenol 6
Fire brick solid; yield 81.07%; m.p. 123 C; Anal. Calcd. for
C13H11NO2: C, 73.23, H, 5.20, N, 6.57; found C, 73.33, H,
5.39, N, 6.63; IR (KBr) mmax cm
1: 1671 (C‚N); 1H NMR
(DMSO-6d, 400 MHz, ppm) d: 8.53 (1H, s, AN‚CH, azome-
thine); EI-MS: m/z [M]+ 213.7.
2.5. 4-[(2-Hydroxyphenylimino)methyl]benzene-1,3-diol 7
Chocolate solid; yield 73.21%; m.p. 132 C; Anal. Calcd. for
C13H11NO3: C, 68.11, H, 4.84, N, 6.11; found C, 68.29, H,
4.97, N, 6.26; IR (KBr) mmax cm
1: 1625 (C‚N); 1H NMR
(DMSO-6d, 400 MHz, ppm) d: 8.76 (1H, s, AN‚CH, azome-
thine); EI-MS: m/z [M]+ 229.1.
2.6. Biological assays
2.6.1. Antioxidant: DPPH radical scavenging assay
The free radical scavenging activity was carried out by 1,1-di-
phenyl-2-picryl-hydrazil (DPPH) (Ferheen et al., 2009). The
solution of DPPH (0.3 lM) was prepared in ethanol. The solu-
tion of each sample was prepared in methanol. Five microliters
of solution of each sample (with concentration range 5–500 lg)
was added to 95 lL of DPPH solution, the mixture was then
dispersed in 96 well plates and placed for 30 min into the incu-
bator at 37 C. Then absorbance was recorded at 515 nm by
elisa plate reader (Spectramax plus 384 Molecular Device,
USA) and percent radical scavenging activity was assessed in
contrast to methanol treated control (DMSO). BHA (butyl-
ated hydroxylanisole) used as standard.
DPPH scavenging effect ð%Þ ¼ AcAs=Ac 100
where Ac, absorbance of control (DMSO treated); As, absor-
bance of sample.
IC50 values were checked by observing the effect of different
concentrations (1–1000 lM) and were calculated using EZ-ﬁt
enzyme kinetic program (Pellera Scientiﬁc Inc. Amherst,
USA).
2.6.2. Urease inhibition assay
The urease enzyme solution was prepared by taking 0.125 units
in each well in phosphate buffer (K2HPO4Æ3H2O, 1 mM
EDTA and 0.01 M LiCl2). Each well was ﬁlled with 80 lL of
0.05 M potassium phosphate buffer (pH 8.2), 10 lL of the
sample (concentration range 5–500 lM), contents were mixed
and incubated for 15 min at 30 C. Forty microliters of sub-
strate solution (urea, 50 mM) was poured in each well for ini-
tiating reaction. Then, 70 lL alkaline reagent (0.5% NaOH
and 0.1% active NaOCl) and 40 lL of phenol reagent (1%
phenol and 0.005% w/v sodium nitroprusside) were introduced
to each well. The well plate, containing reaction mixture, was
Table 1 IC50 values of antioxidant, lipoxygenase inhibition
and urease inhibition activities of the compounds 5–7.
Compound DPPH
scavenging
activity IC50
(lM)
Lipoxygenase
inhibition
activity IC50
(lM)
Urease
inhibition
activity
IC50 (lM)
5 15.3 51.6 +
6 34.0 17.1 +
7 118 67.4 +
BHA 44.2  
Baicalein  22.6 
Thiourea   21.6
+, Non-signiﬁcant.
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IC50 values were determined by monitoring the effect of
increasing concentrations of Schiff bases 5–7 on extent of inhi-
bition (Ferheen et al., 2009).
2.6.3. Lipoxygenase inhibition assay
Hundred and sixty microliters of 100 mM sodium phosphate
buffer (pH 8.0) and 10 lL of sample in methanol (concentra-
tion’s range 5–500 lM) was added to each labeled well.
Twenty microliters of lipoxygenase (LOX) solution (enzyme
130 units per well) was added, mixed and incubated for
10 min at 25 C. The reaction was then initiated by the addi-
tion of 10 lL substrate solution (linoleic acid, 0.5 mM,
0.12% w/v tween 20 in the ratio of 1:2) to each well and the
absorbance was measured after 15 min at 234 nm (Ali et al.,
2009). Baicalein was used as standard
2.6.4. Antibacterial assay
Antibacterial activities of 5–7 were carried out against Gram-
positive: Staphylococcus intermedius, Bacillus subtilis and
Staphylococcus aureus, and Gram-negative: Escherichia coli
and Salmonella typhi bacteria by agar well diffusion method
using Mueller Hinton agar medium. Test sample (200 mg)
was dissolved in 10 ml DMSO (99.9%) and ﬁnal concentration
was made up to 20 mg/mL. The microorganism was grownup
overnight individually in tryptic Soya broth and ﬁnally it
mixed with physiological saline until colony formation was
achieved in accordance with turbidity standard. The agar med-
ium used for individual organisms was Molton Mueller Hinton
agar medium, and used with 10 mL of prepared inoculumTable 2 Results of antibacterial activities of the compounds 5–7.
Bacteria Gentamicin (0.3%) 5
Zone inhibition
(mm)
Zone inhibition
(mm)
Inhibition
(%)
S. intermedius 30 19 63.3
B. subtilis 27 21 77.7
S. aureus 30 20 66.6
E. coli 30 25 83.3
S. typhi 24 16 66.6(inoculum size was 108 cells/ml as per McFarland standard).
It was transferred to 20 · 100 mm petri dishes after proper
homogenization. The required numbers of wells were adjusted
in the seeded plates with the help of a sterile crock-borer
(8.0 mm) after solidiﬁcation. Hundred microliters of test sam-
ple was poured into respective wells. All the plates were incu-
bated at 37 C for 24 h after making positive (gentamicin
0.3%) and negative control (DMSO) plates ready. The diame-
ter of the zone of inhibition and percentage of growth inhibi-
tion was calculated to determine the antibacterial activity
(Bibi et al., 2011).3. Results and discussion
3.1. Chemistry and characterization
The Schiff bases, 2-[(3-hydroxybenzylidene)amino]phenol 5, 2-
[(4-hydroxybenzylidene)-amino]phenol 6 and 4-[(2-hydroxy-
phenylimino)methyl]benzene-1,3-diol 7, were synthesized by
the condensation of 2-aminophenol 1 with 3-hydroxybenzalde-
hyde 2, 4-hydroxybenzaldehyde 3 and 2,4-dihydroxybenzalde-
hyde 4, respectively, in ethanol followed by 3–4 drops of conc.
sulfuric acid as catalyst (Scheme 1). The purity of the products
was checked by TLC and was very pure. Products have sharp
melting points and are stable in air. In the IR spectra of prod-
ucts 5–7, the presence of characteristic bands of azomethine
moiety at 1680, 1671 and 1625 cm1, respectively and the ab-
sence of bands of the carbonyl and amine moieties, reveal
the formation Schiff bases. In the 1H NMR spectra of the com-
pounds 5–7, the singlet of the protons at d 8.56, 8.53 and 8.76,
respectively, evident the formation of azomethine linkage
(Bhattacharjee et al., 2012). The EI mass spectra of the prod-
ucts 5–7, showed that the molecular ion peaks at m/z 213.3,
213.7 and 229.1, respectively, were in complete agreement with
the expected structure. Elemental analyses further supported
the masses and the structures of the products (Scheme 1).
3.2. Biological evaluation
3.2.1. Antioxidant: DPPH radical scavenging study
The antioxidant activity of compounds 5–7 was carried out
with DPPH by a well diffusion method in comparison with
the BHA. The results show that compounds 5 and 6 are potent
antioxidant active while 7 is moderate antioxidant active (Ta-
ble 1). Generally, it is well known that compounds having
functional groups such as –OH, –SH, –COOH, –N, –S–, and6 7
Zone inhibition
(mm)
Inhibition (%) Zone inhibition
(mm)
Inhibition
(%)
26 86.6 23 76.6
23 85.1 18 66.6
24 85.7 22 73.3
23 76.6 26 86.6
19 79.1 14 58.3
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having OH group in their structure, might be for this reason,
the compounds that are antioxidant active.
3.2.2. Urease inhibition study
Compounds 5–7 under investigation were evaluated against
urease enzyme and they showed non-signiﬁcant activity
(Table 1).
3.2.3. Lipoxygenase (LOX) inhibition study
All synthesized compounds 5–7 were screened out for
lipoxygenase inhibition activity in comparison with baicalein.
The results show that compound 6 is potent active while
compounds 5 and 7 are signiﬁcant active against it (Table 1).
May be the reason is that, para-hydroxyl product is more
compatible with LOX than the ortho- and meta-hydroxyl
positions.
3.2.4. Antibacterial study
Antibacterial activities of compounds 5–7 under investigation
were carried out against Gram-positive and Gram-negative:
S. intermedius, B. subtilis, S. aureus, E. coli and S. typhi bacte-
ria by the agar well diffusion method in comparison with gen-
tamicin. All Schiff bases are excellently active against all
bacteria (Table 2). It is reported that Schiff bases having hy-
droxyl moiety in their structures have a greater activity (Reh-
man et al., 2005). Compounds under investigation contain one
and two hydroxyl groups, and due to this reason, these com-
pounds have excellent antibacterial activities.
4. Conclusion
Schiff bases 5–7, were synthesized by the reaction of 2-amino-
phenol 1 and hydroxylbenzaldehydes 2–4 in ethanol. The
Schiff bases 5 and 6 are potent antioxidant agents and 6 is also
a potent lipoxygenase inhibition active. All target compounds
5–7 have excellent antibacterial activities but not urease inhibi-
tion activity at all.Acknowledgments
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